As the DNA extracted from pleural effusion fluid consisted of DNA derived from both tumour cells and normal cells, the EGFR mutation status needs to be evaluated in a pair of DNA specimens from the tumour and pleural effusion fluid to confirm the usefulness of the mutation status determined from pleural effusion fluid. This evidence concerns the gene EGFR and neoplasm.